Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04961710
What this trial is testing

Extension Study of Hetrombopag in Severe Aplastic Anemia

Who this might be right for
Treatment-naive Severe Aplastic Anemia
Jiangsu HengRui Medicine Co., Ltd. 157
Early research (Phase 1)Not Yet RecruitingNCT05181501
What this trial is testing

Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma (FUMANBA-2)

Who this might be right for
Multiple Myeloma
Nanjing IASO Biotechnology Co., Ltd. 20
Post-approval studies (Phase 4)Study completedNCT00207142
What this trial is testing

Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)

Who this might be right for
HIV Infections
Bristol-Myers Squibb 252
Testing effectiveness (Phase 2)Active Not RecruitingNCT04505254
What this trial is testing

Acalabrutinib and Obinutuzumab for the Treatment of Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
M.D. Anderson Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT01087502
What this trial is testing

Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 241
Large-scale testing (Phase 3)Study completedNCT00437112
What this trial is testing

Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 142
Not applicableStudy completedNCT00286767
What this trial is testing

Immune Reconstitution Syndrome in HIV-Infected Patients Taking Antiretroviral Therapy

Who this might be right for
Immune Reconstitution Inflammatory Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 525
Testing effectiveness (Phase 2)Study completedNCT05673577
What this trial is testing

Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Fudan University 41
Not applicableStudy completedNCT05037396
What this trial is testing

Evaluation of Number of Patient Eyes That Remained on or Switched to Anti-VEGF Treatment After Initiation of Broluciumab

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 9,457
Not applicableStudy completedNCT00206960
What this trial is testing

Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia

Who this might be right for
Schizophrenia
Birte Glenthoj 56
Testing effectiveness (Phase 2)Ended earlyNCT03679624
What this trial is testing

Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia

Who this might be right for
Waldenstrom MacroglobulinemiaWaldenstrom's DiseaseWaldenström; Hypergammaglobulinemia+4 more
Weill Medical College of Cornell University 1
Large-scale testing (Phase 3)UnknownNCT02743923
What this trial is testing

Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
The Netherlands Cancer Institute 203
Large-scale testing (Phase 3)UnknownNCT00440284
What this trial is testing

Flexible, Intensive vs. Conventional Insulin Therapy in Insulin-Naive Adults With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Jena 38
Not applicableStudy completedNCT02821247
What this trial is testing

Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
Bayer 119
Post-approval studies (Phase 4)Study completedNCT00107653
What this trial is testing

Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 569
Testing effectiveness (Phase 2)Study completedNCT00110812
What this trial is testing

Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 267
Not applicableStudy completedNCT00002411
What this trial is testing

A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Post-approval studies (Phase 4)Study completedNCT00077636
What this trial is testing

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,469
Large-scale testing (Phase 3)UnknownNCT06182592
What this trial is testing

A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia

Who this might be right for
High-risk (Secondary) Acute Myeloid Leukemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT01092143
What this trial is testing

BI 671800 ED in Steroid-naive Asthmatic Patients

Who this might be right for
Asthma
Boehringer Ingelheim 389
Next Page